T1	Concept 34 39	CD147
T2	Action 40 45	plays
T3	Concept 48 58	functional
T4	Concept 59 63	role
T5	Action 67 79	facilitating
T6	Action 89 97	invasion
T7	Concept 80 88	SARS-CoV
T8	Concept 107 112	cells
T9	Concept 102 106	host
R1	has-property Arg1:T8 Arg2:T9	
R2	subject Arg1:T2 Arg2:T1	
R3	has-property Arg1:T4 Arg2:T3	
R4	target Arg1:T2 Arg2:T4	
R5	in-context Arg1:T2 Arg2:T5	
R6	target Arg1:T5 Arg2:T6	
R7	subject Arg1:T6 Arg2:T7	
R8	in-place Arg1:T6 Arg2:T8	
T10	Concept 118 123	CD147
T11	Concept 124 136	antagonistic
T13	Concept 805 815	amino acid
T12	Concept 858 866	SARS-CoV
T15	Concept 137 146	peptide-9
T16	Concept 889 899	amino acid
R9	has-property Arg1:T15 Arg2:T11	
R10	has-part Arg1:T10 Arg2:T15	
T17	Concept 174 180	HEK293
T18	Concept 181 186	cells
R11	is-a Arg1:T17 Arg2:T18	
T20	Concept 194 204	inhibitory
T21	Action 205 211	effect
R12	has-property Arg1:T21 Arg2:T20	
T22	Action 816 824	homology
R13	subject Arg1:T21 Arg2:T15	
T23	Concept 215 223	SARS-CoV
R14	target Arg1:T21 Arg2:T23	
T24	Concept 158 165	binding
T25	Concept 166 170	rate
R15	has-property Arg1:T25 Arg2:T24	
A1	Emphasized T25
R18	in-context Arg1:T24 Arg2:T17	
R19	has-property Arg1:T15 Arg2:T25	
T27	Concept 234 243	2019-nCoV
T28	Concept 244 250	genome
T26	Concept 290 303	2002 SARS-CoV
T29	Concept 304 310	genome
T30	Concept 315 323	proteome
T31	Action 272 282	similarity
A2	Emphasized T31
R16	has-part Arg1:T27 Arg2:T28	
R20	subject Arg1:T31 Arg2:T28	
R21	has-part Arg1:T29 Arg2:T26	
R22	has-part Arg1:T30 Arg2:T26	
R23	target Arg1:T31 Arg2:T29	
R17	target Arg1:T31 Arg2:T30	
T19	Action 872 877	noted
T32	Action 900 911	differences
T33	Concept 387 391	SARS
T34	Concept 392 400	proteome
T35	Concept 437 446	2019-nCoV
T36	Concept 447 455	proteome
T38	Concept 358 370	interactions
T39	Action 371 379	observed
T41	Concept 928 934	models
R25	subject Arg1:T39 Arg2:T38	
T42	Concept 939 953	identity scale
R26	in-place Arg1:T39 Arg2:T34	
A3	Emphasized T38
T43	Action 420 429	preserved
A4	Uncertain T43
R27	subject Arg1:T43 Arg2:T38	
R24	has-part Arg1:T33 Arg2:T34	
R30	has-part Arg1:T35 Arg2:T36	
R31	in-place Arg1:T43 Arg2:T36	
T44	Action 509 517	affected
A5	Negated T44
T45	Concept 490 497	binding
T46	Concept 498 503	sites
R33	has-property Arg1:T46 Arg2:T45	
R34	in-context Arg1:T43 Arg2:T44	
R35	target Arg1:T44 Arg2:T46	
R36	target Arg1:T32 Arg2:T16	
R37	entails Arg1:T31 Arg2:T43	
T47	Concept 559 568	treatment
T48	Concept 552 558	plasma
R40	in-context Arg1:T47 Arg2:T48	
T37	Concept 881 884	red
T40	Concept 915 919	blue
T49	Concept 626 634	SARS-CoV
T50	Concept 649 667	severe influenza A
T51	Concept 669 673	H1N1
*	same-as T50 T51
T52	Concept 635 644	infection
T53	Action 569 576	reduced
T54	Concept 590 594	stay
T55	Concept 581 589	hospital
T56	Concept 599 608	mortality
R43	in-place Arg1:T54 Arg2:T55	
R44	target Arg1:T53 Arg2:T54	
R45	target Arg1:T53 Arg2:T56	
T14	Concept 837 844	modeled
T57	Concept 845 853	proteins
R28	has-property Arg1:T57 Arg2:T14	
R29	target Arg1:T22 Arg2:T12	
R32	target Arg1:T22 Arg2:T57	
R46	in-context Arg1:T22 Arg2:T13	
R47	target Arg1:T19 Arg2:T22	
R42	target Arg1:T19 Arg2:T32	
R48	in-context Arg1:T40 Arg2:T32	
R39	in-context Arg1:T37 Arg2:T22	
R38	in-place Arg1:T19 Arg2:T41	
R41	in-place Arg1:T19 Arg2:T42	
